|
XOMA | Xoma Royalty Corp |
|
|
XOMA | Xoma Royalty Corp |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.36 |
| Leverage | 58.98% |
| Market Cap | $ 299.8m |
| PE | 14.05 |
| Dividend Yield | 0.00% |
| Profit | $ 21.3m |
| Margin | 37.80% |
XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.